Your session is about to expire
← Back to Search
Pharmacokinetics Study of Atropine Oral Gel
Study Summary
This trial looks at how atropine gel is absorbed into the bloodstream after being applied to the mouth.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had acute hepatitis, cirrhosis, or severe liver issues in the last 6 months.I have a history of chronic lung disease or COPD.I have a partial blockage in my stomach or similar digestive issues.I am currently taking anticholinergic medications.I am currently on immunosuppressive therapy.I have signed the consent form.I have a heart condition like heart failure or arrhythmia.I have noticeable changes in my mouth's shape or structure.I am currently receiving treatment for an infection.I have acute glaucoma that worsens with atropine.I have had radiotherapy for head or neck cancer.I am currently pregnant or nursing.I am currently taking medication for depression or Parkinson's disease.My kidney function is severely impaired.I have not had chemotherapy or radiotherapy in the last 3 months.I have been diagnosed with difficulty emptying my bladder.I have had blockages or stones in my salivary glands before.
- Group 1: 0.1 mg of atropine
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any other research investigations that have utilized Atropine sulfate gel (0.01%)?
"At this juncture, 6 investigations of Atropine sulfate gel (0.01%) are in their final Phase 3 and a total of 22 trials are operating globally; with the majority based out of Shanghai, China. Currently 149 medical facilities host clinical trial for Atropine sulfate gel (0.01%)."
Does the protocol for this research project include participants under 85 years of age?
"The age parameters of this investigation necessitate participants to be above 18 years old, but younger than 50."
In what clinical circumstances is Atropine sulfate gel (0.01%) typically utilized?
"Atropine sulfate gel (0.01%) is a useful intervention for managing ailments such as laughter, pupillary dilation and rhinorrhoea."
Am I eligible for enrollment in this experiment?
"Eligibility for this research requires that applicants possess cerebral palsy and be within the ages 18-50. Approximately 10 participants will be admitted to the trial."
How many participants are engaged with this clinical examination?
"Yes, according to clinicaltrials.gov, this medical research is actively recruiting patients. It was initially posted on October 1st 2022 and subsequently amended on November 1st 2022 with the goal of enrolling 10 participants at a single site."
Are there still vacancies for this clinical trial?
"Per information on clinicaltrials.gov, this medicinal investigation is actively in search of participants. This trial was initially posted on the 1st October 2022 and most recently updated on the 1st November 2022."
Share this study with friends
Copy Link
Messenger